Atlas Trials

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Clinical trial NCT05535829 · UNKNOWN

Trial details

NCT number
NCT05535829
Sponsor
RenJi Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
FH-Deficient RCCSystemic TreatmentsBiomarkers
Start date
2022-08-01
Primary completion
2024-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.